Blog: The Myriad gene patent case: its potential impact on the...

Aug 1, 2012 | Posted by: roboblogger | Full story: Mass High Tech

Recently, a federal appeals court heard oral arguments in a patent case, the ruling in which could significantly impact Massachusetts-based academic research organizations, biotechnology companies, and pharmaceutical companies.

Comments
1 - 2 of 2 Comments Last updated Aug 6, 2012
Julius

United States

|
Report Abuse
|
Judge it!
|
#1
Aug 6, 2012
 
Does Mitt Romney/Bain Capital have financial interests in Utah diagnostic company Myriad Genetics?
dexter

United States

|
Report Abuse
|
Judge it!
|
#2
Aug 6, 2012
 
Seems as if someone should look into this. Do you have information on this matter? You seem to be suggesting such given your question.

Tell me when this thread is updated: (Registration is not required)

Add to my Tracker Send me an email

Type in your comments below
Name
(appears on your post)
Comments
Characters left: 4000
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

•••
•••